Red cell antigen phenotypes in blood donors & thalassaemia patients for creation of red cell antigen-matched inventory

• Published in: Indian journal of medical research (New Delhi, India : 1994) India : 1994), 2020-09, Vol.152 (3), p.273-279
• Main Authors: Kulkarni, Swati, Choudhary, Bhavika, Gogri, Harita, Sharma, Jayashree, Madkaikar, Manisha
• Format: Article
• Language: English
• Subjects: Antigens; Blood & organ donations; Blood diseases; Blood donation; Blood Donors; Blood Group Antigens; Blood Grouping and Crossmatching; Blood groups; EDTA; Erythrocytes; Genetic aspects; Humans; Isoantibodies; Original; Phenotype; Thalassemia - therapy
• ISSN: 0971-5916; 0975-9174
• DOI: 10.4103/ijmr.IJMR_1199_18

Background & objectives: Patients with thalasssaemia are at a risk of alloimmunization and the presence of RBC alloantibodies further complicates transfusion therapy. Matching for the critical antigens of Rh, Kell, Kidd and Duffy blood group systems has been shown to minimize alloimmunization. The aim of the present study was to create a database of extensively typed donors for clinically significant and common blood group antigens of Rh, Kidd, Kell and Duffy systems for transfusion therapy of multitransfused thalassaemic patients. Methods: Five hundred O group regular blood donors were phenotyped for Rh, Kell, Duffy and Kidd blood group antigens using haemagglutination technique. Eighty four non-alloimmunized and 15 alloimmunized thalassaemia major patients with known antigenic profiles (determined by polymerase chain reaction with sequence-specific primers) were selected for this study. Results: By analyzing antigen profiles of 500 O group regular donors, a database of 193 donors matching perfectly for Rh, Duffy, Kell and Kidd antigens was prepared for 15 alloimmunized patients. For non-alloimmunized 84 thalassaemic patients, a database of 405 donors was created. Interpretation & conclusions: A database of 500 regular blood donors phenotyped for common antigens of Rh, Duffy, Kell and Kidd blood group systems was created, which would be useful in providing extended antigen-matched RBCs for thalassaemia patients. This will improve the quality and effectiveness of transfusion therapy.